Skip to main content
SpringerLink
Log in

Rotavirus vaccine may be worthwhile in New Zealand

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Milne RJ, Grimwood K.Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule. Value in Health 12: 888-898, No. 6, Sep 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rotavirus vaccine may be worthwhile in New Zealand. Pharmacoecon. Outcomes News 588, 7 (2009). https://doi.org/10.2165/00151234-200905880-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905880-00014

Keywords

Search

Navigation